Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Nov;33(11):1504-7.
doi: 10.1136/gut.33.11.1504.

Coeliac disease: characterisation of monoclonal antibodies raised against a synthetic peptide corresponding to amino acid residues 206-217 of A-gliadin

Affiliations

Coeliac disease: characterisation of monoclonal antibodies raised against a synthetic peptide corresponding to amino acid residues 206-217 of A-gliadin

H J Ellis et al. Gut. 1992 Nov.

Abstract

A dodecapeptide of A-gliadin, which shares amino acid homologies with the E1b protein of adenovirus 12, was used to produce murine monoclonal antibodies. Five monoclonal antibodies were produced and were screened by enzyme linked immunosorbant assay, immunodot assay, and immunoblotting. The antibodies were tested against whole wheat gliadin and its alpha, beta, gamma, and omega subfractions, and the prolamins of rye, barley, oats, maize, millet, rice, and sorghum. Four of the five antibodies cross reacted with one or more of the coeliac non-toxic cereals--maize, millet, sorghum, and rice. The monoclonal antibody that did not cross react with these non-toxic cereals, did not recognize Frazer's fraction III, a peptic-tryptic digest of wheat gluten which is known to be toxic. The results suggest that the A-gliadin dodecapeptide shares a region of homology with cereals that do not exacerbate coeliac disease. This study does not support the hypothesis that prior infection with adenovirus 12 is a precipitating factor in coeliac disease.

PubMed Disclaimer

Similar articles

Cited by

  • Molecular mimicry in autoimmune disease.
    Leech S. Leech S. Arch Dis Child. 1998 Nov;79(5):448-51. doi: 10.1136/adc.79.5.448. Arch Dis Child. 1998. PMID: 10193262 Free PMC article. Review. No abstract available.
  • Immune development and intestinal microbiota in celiac disease.
    Pozo-Rubio T, Olivares M, Nova E, De Palma G, Mujico JR, Ferrer MD, Marcos A, Sanz Y. Pozo-Rubio T, et al. Clin Dev Immunol. 2012;2012:654143. doi: 10.1155/2012/654143. Epub 2012 Sep 11. Clin Dev Immunol. 2012. PMID: 23008734 Free PMC article. Review.
  • Molecular biology of coeliac disease.
    Tighe R, Ciclitira PJ. Tighe R, et al. Arch Dis Child. 1995 Sep;73(3):189-91. doi: 10.1136/adc.73.3.189. Arch Dis Child. 1995. PMID: 7492152 Free PMC article. No abstract available.

References

    1. J Immunol. 1979 Oct;123(4):1548-50 - PubMed
    1. Scand J Gastroenterol. 1991 Apr;26(4):392-8 - PubMed
    1. Biochem J. 1990 Sep 1;270(2):313-8 - PubMed
    1. Gut. 1989 Nov;30(11):1563-7 - PubMed
    1. Gut. 1987 Aug;28(8):995-1001 - PubMed

Publication types

MeSH terms